Terns Pharmaceuticals (TERN) Earnings Date & Reports
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TERN is expected to report earnings to rise 12.30% to -30 cents per share on March 31
Q4'25
Est.
$-0.30
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.06
The last earnings report on November 10 showed earnings per share of -27 cents, beating the estimate of -30 cents. With 1.22M shares outstanding, the current market capitalization sits at 1.83B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TERN showed earnings on November 10, 2025. You can read more about the earnings report here.